Andrew_Byrnes

Andrew Byrnes

CDER, FDA

Dr. Byrnes is Chief of the Gene Transfer and Immunogenicity Branch in the Division of Cellular and Gene Therapies at FDA’s Center for Biologics Evaluation and Research. Dr. Byrnes received his undergraduate degree from Yale University, earned his Ph.D. from the University of Oxford, and then conducted postdoctoral research at Johns Hopkins University. Dr. Byrnes has 20 years of experience at FDA in review of manufacturing of gene therapies, cell therapies and other products for clinical use. Dr. Byrnes has a background in virology and gene therapy, and his laboratory research focuses on adenovirus gene therapy in rodent models. Research interests include vector biodistribution, clearance of vector by the liver, interactions of virions with natural antibodies and complement, and innate immune reactions to viral vectors.


Appearances